Retrospective Study Evaluating the Contribution of Rheopheresis in the Treatment of Uremic Calciphylaxis (RHEO-CUA)

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

May 20, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

September 30, 2023

Conditions
RheopheresisCalcifying Uremic ArteriolopathyUremic Calciphylaxis
Interventions
PROCEDURE

Rheopheresis

Technique of apheresis in double filtration, allowing the extraction of molecules of high molecular weight, and thus the improvement of the rheological conditions of microcirculation. The expected effect is the improvement of tissue oxygenation and the acceleration of the healing of skin lesions, with the consequent reduction of infectious complications.

Trial Locations (1)

72000

ECHO - Pole Santé Sud, Le Mans

All Listed Sponsors
collaborator

European Clinical Trial Experts Network

OTHER

collaborator

Elsan

OTHER

lead

Association ECHO

OTHER

NCT05633121 - Retrospective Study Evaluating the Contribution of Rheopheresis in the Treatment of Uremic Calciphylaxis (RHEO-CUA) | Biotech Hunter | Biotech Hunter